innate immunity

AB1164 ACCUMULATION OF MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES IN SYSTEMIC SCLEROSIS
A. Manfredi, N. Maugeri, G. A. Ramirez, A. Capobianco, A. Monno, F. Iannone, S. Franchini

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1915-1916; DOI: 10.1136/annrheumdis-2024-eular.2813
AB1163 TYPE 1 INTERFERON SIGNATURE IN SYSTEMIC SCLEROSIS
Y. Allanore, A. Cauvet, M. Schwarz, J. Avouac

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1915; DOI: 10.1136/annrheumdis-2024-eular.2775
AB1165 LAG-3 IS IMMUNE-PROTECTIVE IN SYSTEMIC SCLEROSIS
M. Aspari, S. R. Greisen, V. Ong, K. Soendergaard, E. Naeser, C. P. Denton, D. Abraham, B. Deleuran, on behalf of Bent Deleuran’s Group

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1916; DOI: 10.1136/annrheumdis-2024-eular.3742
AB0976 PLASMA PROTEIN INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN 4 (ITIH4) LEVELS IN PATIENTS WITH axSpA AND RESPONSE TO TNF-INHIBITOR THERAPY
C. E. Mistegaard, A. Troldborg, A. G. Hansen, A. G. Jurik, R. M. Kiil, A. A. Christiansen, B. Schiøttz-Christensen, O. Hendricks, S. Juhl Pedersen, I. J. Sørensen, M. Østergaard, A. G. Loft, S. Thiel

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1801-1802; DOI: 10.1136/annrheumdis-2024-eular.3810
AB0977 INVESTIGATING THE EFFECTS OF DISEASE ACTIVITY AND HYPOXIA ON IMMUNE RESPONSES TO GUT BACTERIA IN ANKYLOSING SPONDYLITIS
E. Peyroux, S. Stebbings

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1802-1803; DOI: 10.1136/annrheumdis-2024-eular.6097
AB1072 INFECTIOUS EVENTS AND INITIAL SELENA-SLEDAI POSITIVELY CORRELATE WITH AN INCREASED RISK OF FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
R. Borrelli, N. Rashidy, A. Quinternetto, I. Vitali, F. Meli, M. Mazzola, E. Saracco, F. Corradi, I. Badiu, L. Lo Sardo, S. Nicola, L. Brussino

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1852-1853; DOI: 10.1136/annrheumdis-2024-eular.474
AB0754 ANTI-IL-6 RECEPTOR INTERVENTION STRONGLY ATTENUATES MACROPHAGE AND T-CELL ACTIVITY
D. Sinkeviciute, S. F. Madsen, M. Bajaj, P. Drobinski, M. Karsdal, A. C. Bay-Jensen

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1668-1669; DOI: 10.1136/annrheumdis-2024-eular.5578
AB0771 ENHANCED EXPRESSION OF MRNA FOR INTERFERON SIGNATURE GENES IN CD34+ CELLS OF THE BONE MARROW IN RHEUMATOID ARTHRITIS
S. Hirohata, T. Tomita

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1676-1677; DOI: 10.1136/annrheumdis-2024-eular.1097
AB0782 IN VITRO EFFECT OF UPADACITINIB AND TOFACITINIB ON PERIPHERAL BLOOD LEUKOCYTES FROM PATIENTS WITH EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS
R. L. Teixeira, C. A. Bento, C. Tomé, V. C Romão, J. E. Fonseca, I. Alcobia, R. A. Moura

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1683-1684; DOI: 10.1136/annrheumdis-2024-eular.5197
AB0795 IL-1 PATHWAY IN SJÖGREN’S SYNDROME: THE ROLE IN AUTOIMMUNE EPITHELITIS
R. Izzo, E. Simoncelli, S. Colafrancesco, A. Gattamelata, L. Mastromanno, M. Villa, I. Fischetti, C. Barbati, G. Buoncuore, F. Conti, R. Priori

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1691-1692; DOI: 10.1136/annrheumdis-2024-eular.1576

Main menu

innate immunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

innate immunity

Pages